Hence, we performed several experiments in vivo to highlight TLR2 as a risk gene for AP that amplifies local inflammation and pancreatic injuries by inducing pro-inflammatory neutrophil activation. The gene discussed is TLR2; the disease is alkaline phosphatase measurement.